Voluntary Scheme for Branded Medicines Pricing and Access

(asked on 16th March 2023) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will publish (a) the minutes from and (b) a list of attendees at the workshops his Department has been running ahead of negotiations on a new Voluntary Scheme for Branded Medicines Pricing and Access.


Answered by
Will Quince Portrait
Will Quince
This question was answered on 23rd March 2023

The objective of the pre-negotiation workshops was to enable a mutual understanding of the impact of the current voluntary scheme upon the different organisations represented, and to discuss the potential objectives and priorities for a new voluntary scheme. The discussions in the workshops will feed into the upcoming negotiation of a successor to the 2019 voluntary scheme for branded medicines pricing and access. In order to facilitate a transparent and candid discussion, participants agreed that all contributions would be kept confidential to those who attended.

The following external organisations were invited to the workshops:

Industry bodies:

- Association of the British Pharmaceutical Industry

- British Generic Manufacturers Association

- Ethical Medicines Industry Group

- BioIndustry Association

Patient organisations and civil society organisations:

- Cancer52

- The Blood Cancer Alliance

- The Charity Medicines Access Coalition

- National Voices

- The Patients Association

- Alzheimer’s Research UK

- Anthony Nolan

- Cystic Fibrosis Trust

- Genetic Alliance UK

- The Association of Medical Research Charities

- Breast Cancer Now

- Myeloma UK

- Office of Health Economics

- King’s Fund

- NHS Confederation

Reticulating Splines